Synovus Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,973
| Closed | -$907K | – | 890 |
|
|
2022
Q4 | $907K | Sell |
7,973
-1,826
| -19% | -$208K | 0.01% | 480 |
|
|
2022
Q3 | $607K | Buy |
9,799
+596
| +6% | +$36.9K | 0.01% | 532 |
|
|
2022
Q2 | $730K | Sell |
9,203
-1,993
| -18% | -$158K | 0.01% | 486 |
|
|
2022
Q1 | $1.18M | Buy |
11,196
+895
| +9% | +$94.4K | 0.01% | 415 |
|
|
2021
Q4 | $1.11M | Buy |
10,301
+189
| +2% | +$20.3K | 0.01% | 427 |
|
|
2021
Q3 | $1.11M | Sell |
10,112
-4,316
| -30% | -$472K | 0.01% | 410 |
|
|
2021
Q2 | $1.34M | Sell |
14,428
-940
| -6% | -$87.6K | 0.01% | 361 |
|
|
2021
Q1 | $1.41M | Sell |
15,368
-353
| -2% | -$32.5K | 0.02% | 314 |
|
|
2020
Q4 | $1.14M | Buy |
15,721
+446
| +3% | +$32.5K | 0.01% | 350 |
|
|
2020
Q3 | $1.18M | Buy |
15,275
+296
| +2% | +$22.8K | 0.02% | 329 |
|
|
2020
Q2 | $833K | Sell |
14,979
-2,096
| -12% | -$117K | 0.01% | 360 |
|
|
2020
Q1 | $503K | Buy |
17,075
+4,112
| +32% | +$121K | 0.01% | 511 |
|
|
2019
Q4 | $472K | Sell |
12,963
-2,473
| -16% | -$90K | 0.01% | 483 |
|
|
2019
Q3 | $418K | Buy |
15,436
+15,258
| +8,572% | +$413K | 0.01% | 497 |
|
|
2019
Q2 | $4K | Hold |
178
| – | – | ﹤0.01% | 1274 |
|
|
2019
Q1 | $5K | Hold |
178
| – | – | ﹤0.01% | 1239 |
|
|
2018
Q4 | $3K | Hold |
178
| – | – | ﹤0.01% | 1297 |
|
|
2018
Q3 | $3K | Buy |
+178
| New | +$3K | ﹤0.01% | 1315 |
|